Delpharm Sustainability Reports
Delpharm operates as a contract development and manufacturing organization (CDMO) for the pharmaceutical industry. The company specializes in the development, formulation, production, and packaging of human and veterinary medicines across solid, liquid, semi-solid, and sterile forms.
Sector: Manufacturing
Country: France
Exchange: Unlisted
LEI: 9695007L2VAHR7SYV822
3 reports from 2024 to 2025
